CoChat

Nrf2 defense pathway: Experimental evidence for its protective role in epilepsy

Mazzuferi, Manuela, Kumar, Gaurav, van Eyll, Jonathan, Danis, Benedicte, Foerch, Patrik, Kaminski, Rafal M. · 2013 · Annals of Neurology
Cited by 133

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Objective: Epigenetic mechanisms involved in transcriptional regulation of multiple molecular pathways are potentially attractive therapeutic interventions for epilepsy, because single target therapies are unlikely to provide both anticonvulsant and disease‐modifying effects. Methods: A selection of epilepsy‐related gene expression data sets were retrieved using NextBio software and imported to Ingenuity Pathway Analysis for transcription factor enrichment analysis. Nuclear factor erythroid 2‐related factor 2 (Nrf2)—a transcription factor that promotes the expression of numerous antioxidant, anti‐inflammatory, and neuroprotective proteins—was identified as a candidate for confirmation of mRNA expression in hippocampal tissue from patients with temporal lobe epilepsy and in mice following pilocarpine‐induced status epilepticus (SE). Human Nrf2 was overexpressed via an adeno‐associated virus (AAV) vector after the onset of spontaneous recurrent seizures (SRS) in the animals. At the end of a 5‐week continuous monitoring period for SRS, quantitative immunohistochemistry using neuronal (neuronal‐specific nuclear protein), astrocytic (glial fibrillary acidic protein), and microglial (ionized calcium binding adaptor molecule 1) markers was performed. Results: A significant increase in Nrf2 mRNA expression was observed in human epileptic hippocampal tissue. Nrf2 expression levels increased progressively in mice, reaching a peak at 72 hours after SE, and then declined. Similar expression patterns were observed for 3 Nrf2‐regulated genes: HO‐1, NQO1, and mGST. Remarkably, mice injected with AAV Nrf2 displayed significantly fewer generalized seizures, with profound reduction in microglia activation. Hippocampal neurons were preserved, whereas the number of astrocytes was unchanged. Interpretation: These findings extend the potential of Nrf2‐based therapies to epilepsy and add to the rapidly accumulating evidence from other neurodegenerative and inflammatory disease models. Ann Neurol 2013;74:560–568

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.23940

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 133

Metadata

Authors
Mazzuferi, M., Kumar, G., van Eyll, J., Danis, B., Foerch, P., & Kaminski, R. M.
Venue
Annals of Neurology
Publisher
Wiley
Published
2013-07-03
Volume
74
Issue
4
Pages
560-568
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W1482023004
Cited by
133
References
5
FWCI
6.38
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nrf2 defense pathway: Experimental evidence for its protective role in epilepsy. https://app.cochat.ai/papers/10.1002/ana.23940
The paper
Mazzuferi, M., Kumar, G., van Eyll, J., Danis, B., Foerch, P., & Kaminski, R. M. (2013). Nrf2 defense pathway: Experimental evidence for its protective role in epilepsy. Annals of Neurology. https://doi.org/10.1002/ana.23940

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.